Retina dose as a predictor for visual acuity loss in 106 Ru eye plaque brachytherapy of uveal melanomas
نویسندگان
چکیده
منابع مشابه
Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
PURPOSE To report on conservation of visual acuity after Ruthenium(106) (Ru-106) brachytherapy of choroidal melanoma. METHODS AND MATERIALS This study was a noncomparative interventional case series of 458 patients with choroidal melanoma treated at a single center between January 1993 and December 2001. The intervention consisted of Ru-106 brachytherapy delivering minimum scleral and apex do...
متن کاملBrachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
Background: Brachytherapy is the most commonly used conservative treatment for the uveal melanoma. The aim of this study was to evaluate therapeutic results of Ruthenium-106 plaque brachytherapy in the management of localized uveal melanoma cases. Methods: We reviewed retrospectively the clinical records of all patients treated in our department for an uveal melanoma, undergoing Ruthenium-106 p...
متن کاملTumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
BACKGROUND To report on radiation-related side effects and complications after ruthenium-106 plaque brachytherapy of uveal melanomas. METHODS Medical records of 143 eyes with uveal melanoma, treated by ruthenium-106 brachytherapy between 1997 and 2012 at a single center, were analyzed. We evaluated the occurrence of radiation-related side effects on the anterior and posterior segment of the e...
متن کاملbrachytherapy Ru plaque 106 melanomas following Predicting local control of choroidal
Background We evaluated the control rate of choroidal melanomas treated with Ru plaque brachytherapy to identify the risk factors associated with local recurrence and lack of response. Methods A retrospective review of Ru plaque brachytherapy for patients with choroidal melanoma treated at St Bartholomew’s Hospital, London. Survival analysis was used to assess associations between evaluated age...
متن کاملRuthenium-106 Brachytherapy for Uveal Melanomas – Preliminary Results: a Single Institutional Experience*
OBJECTIVE: To analyze the early response of uveal melanomas in patients treated with ruthenium-106 brachytherapy. MATERIALS AND METHODS: In the period between April 2002 and July 2003, 20 patients diagnosed with uveal melanoma were submitted to ruthenium-106 brachytherapy. The calculated dose delivered at the apex of the tumor ranged between 55 Gy and 100 Gy. Patients with lesions greater than ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2018
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2017.11.010